The Rollings Cancer Center (HCC) is directed by Andrew S. Kraft, MD (Director) with the assistance of Anthony J. Alberg, PhD, MPH (Associate Director of Cancer Prevention &Control);Daniel J. Fernandes, PhD (Associate Director of Translational Research);Marvella E. Ford, PhD (Associate Director of Cancer Disparities);Yusuf A. Hannun, MD (Associate Director of Basic Sciences);Anita L. Harrison, MPA (Associate Director of Administration);Carolyn E. Reed, MD (Associate Director of Medical Affairs);Steven A. Rosenzweig, PhD (Assistant Director of Shared Resources);and Melanie B. Thomas, MD (Associate Director of Clinical Investigations). These experienced individuals are organized as a Senior Leadership team that represents the strong functional nexus of this matrix-based Center. Dr. Kraft has charged the members of the team with employing consensus building techniques as they work directly with the various HCC boards/councils and committees to formulate priorities, strategies and allocation of resources. The Senior Leadership team works together to ensure consistency in the vision and goals of the Center;develop synergistic interactions among the basic, translational, and clinical elements of the Center;plan proactive approaches to the development of the research base and resources;effectively leverage all available resources at MUSC and at the state and national levels;engage in community outreach;and oversee all activities of the HCC. The Senior Leadership team meets several times a month in the context of HCC's various board/committee/council meetings, one-on-one with the Director, and once a month as a formal Executive Council. They provide direct counsel and recommendations to the Director based on these interactions. All final authority for decisions on behalf of the HCC resides with the Director.
Support is requested for several members of the HCC Senior Leadership who provide counsel and recommendations to the Director as it pertains to the strategic planning and evaluation of the Center's efforts.
|Barton, Virginia; Armeson, Kent; Hampras, Shalaka et al. (2017) Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res 309:243-251|
|Alexander-Bryant, Angela A; Zhang, Haiwen; Attaway, Christopher C et al. (2017) Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo. Oral Oncol 72:123-131|
|Kim, Sungjin; Alsaidan, Omar Awad; Goodwin, Octavia et al. (2017) Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression. Cancer Res 77:6950-6962|
|Yang, Aimin; Qin, Shenghui; Schulte, Bradley A et al. (2017) MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. Cancer Res 77:6641-6650|
|Karam, Joseph A; Parikh, Rasesh Y; Nayak, Dhananjaya et al. (2017) Co-chaperone Hsp70/Hsp90-organizing protein (Hop) is required for transposon silencing and Piwi-interacting RNA (piRNA) biogenesis. J Biol Chem 292:6039-6046|
|Mehrotra, Shikhar; Britten, Carolyn D; Chin, Steve et al. (2017) Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol 10:82|
|Sagar, Amin; Arif, Ehtesham; Solanki, Ashish Kumar et al. (2017) Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function. Sci Rep 7:12047|
|Liu, Qinlong; Rehman, Hasibur; Krishnasamy, Yasodha et al. (2017) 8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantation. Int J Physiol Pathophysiol Pharmacol 9:69-83|
|Ghatak, Shibnath; Hascall, Vincent C; Markwald, Roger R et al. (2017) Transforming growth factor ?1 (TGF?1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem 292:10490-10519|
|Lemasters, John J (2017) Evolution of Voltage-Dependent Anion Channel Function: From Molecular Sieve to Governator to Actuator of Ferroptosis. Front Oncol 7:303|
Showing the most recent 10 out of 369 publications